Clinical Trials of Cancer
A section of Cancers (ISSN 2072-6694).
Section Information
Cancers seeks to publish interesting articles reporting results of early or late phase clinical trials on any topic connected with clinical oncology. Topics include, but are not limited to, the following:
- Breast cancer
- Developmental therapeutics
- Endocrine system cancer
- Gastrointestinal cancer
- Genitourinary cancer
- Gynecological cancer
- Hematological cancer
- Head and neck cancer
- Neurooncology
- Pediatric oncology
- Thoracic oncology
- Sarcoma
- Skin cancer
- Epidemiology, cancer prevention, and cancer control
- Supportive care
- Imaging
- Health care systems
We invite submission of all clinical trials, whether phase 1, 2, 3, or 4. For phase 1 trials, we especially encourage those that investigate a novel substance for a novel indication, a strong or unexpected beneficial or adverse response, or a novel mechanism of action.
We require registration of all interventional trials, whether early or late phase, in a primary register that participates in the WHO International Clinical Trial Registry Platform or in ClinicalTrials.gov, in accordance with the International Committee of Medical Journal Editors (ICMJE) recommendations.
Reports of trials must conform to the Consolidated Standards of Reporting Trials (CONSORT) 2010 guidelines and be submitted with a full protocol in English or with the full protocol and a synopsis in English that includes details of enrolment criteria, outcomes/endpoints, and statistical considerations.
All reports of randomized trials should include a section entitled “Randomization and Masking” within the Methods Section.Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Breast Cancer: Clinical Trial and Translational Research (Deadline: 23 October 2023)
- Identification of the Targets to Overcome Clinical Problems in Bladder Cancer (Deadline: 31 October 2023)
- Cancer Dormancy: Linking Laboratory and Clinical Findings (Deadline: 31 October 2023)
- Experimental and Clinical Advances in Counteracting Progression of Solid Cancers Volume II (Deadline: 31 October 2023)
- Advances in Clinical Trials of Hematological Malignancies (Deadline: 1 November 2023)
- New Insights into Clinical and Translational Research in Nasopharyngeal Carcinoma (Deadline: 10 November 2023)
- Prognostic Factors in Urologic Cancers—Assessment and Integration into Clinical Care (Deadline: 20 November 2023)
- New Horizons and Surgical Decision Making in HPB Cancer (Deadline: 20 November 2023)
- Clinical Application of Head and Neck Cancer Research (Deadline: 30 November 2023)
- Resistance to Targeted Therapies in Hematological Malignancies (Deadline: 30 November 2023)
- Insights and Advances in the Surgical Management of Hepatocellular Carcinoma (Deadline: 30 November 2023)
- Clinical Utility of Circulating Tumour Cells (Deadline: 30 November 2023)
- Precision Medicine Approaches to Tackle RAS/RAF-Mutant Cancer (Deadline: 10 December 2023)
- PARP Inhibitors in Cancers (Deadline: 20 December 2023)
- Steps towards the Clinics in Spatially Fractionated Radiation Therapy (Deadline: 31 December 2023)
- Advances in Bone Tumor and Sarcoma (Deadline: 31 December 2023)
- The Clinical Trials and Management of Acute Myeloid Leukemia (Deadline: 26 January 2024)
- Merkel Cell Carcinoma: Clinical Challenges and New Developments (Deadline: 31 January 2024)
- Targeted Treatment of Brain Cancer: From Basic Research to Clinical Relevance in the Treatment of Glioma Patients (Deadline: 31 January 2024)
- Integrating Tumor Evolution Dynamics into the Treatment of Cancer (Deadline: 31 January 2024)
- Clinical and Translational Research in Head and Neck Cancer (Deadline: 31 January 2024)
- The Multidimensional Landscape of Pancreatic Cancer Research (Deadline: 20 February 2024)
- Clinical Trials in Gastroesophageal Cancer (Deadline: 23 February 2024)
- Advances in Antitumor Molecular-Targeted Agents of Urological Cancers (Deadline: 29 February 2024)
- Stereotactic Body Radiation and Stereotactic Ablative Radiotherapy Therapy for Cancers (Deadline: 29 February 2024)
- Clinical Management and Prognosis of Gynecological Cancer (Deadline: 29 February 2024)
- Clinical Development and Challenges in Liver Transplantation for Hepatocellular Carcinoma (Deadline: 29 February 2024)
- Clinical PET Studies in Neuro-Oncology (Volume II) (Deadline: 1 March 2024)
- Gastrointestinal Oncology: Clinical Management (Deadline: 31 March 2024)
- Advances in Laparoscopic Surgery and Minimally Invasive Strategies in Gastrointestinal Cancer (Deadline: 31 March 2024)
- Clinical Trials for Pancreatic Cancer Diagnosis and Treatment (Deadline: 31 March 2024)
- Translational Research in Gynecologic Cancer (Deadline: 31 March 2024)
- Clinical Treatment of Osteosarcoma (Deadline: 31 March 2024)
- Gynecologic Cancers: Clinical Research Progress of Resection (Deadline: 31 March 2024)
- Current Clinical Studies of Pancreatic Ductal Adenocarcinoma (Deadline: 20 April 2024)
- The State of the Art in the Diagnosis, Staging, Treatment and Prognosis of Gastrointestinal and Urogenital Malignancies (Deadline: 30 April 2024)
- Clinical Pharmacology in Cancer (Deadline: 30 April 2024)
- Classification, Risk Assessment and Clinical Management of Malignant Thyroid Nodules (Deadline: 30 April 2024)
- Clinical and Research Progress in the Resection of Gastro-Esophageal Cancer (Deadline: 15 May 2024)
- Clinical Trials of the Relationship between Dietary Patterns and Overall Cancer Survival (Deadline: 31 May 2024)
- Lymph Node Dissection in Colorectal Cancer (Deadline: 31 May 2024)
- Clinical Research Advances in Endometrial Carcinoma (Deadline: 31 May 2024)
- The Evolving Treatment and Clinical Trials of Hepatocellular Carcinoma (Deadline: 31 May 2024)
- Bone and Soft Tissue Tumors: Molecular Mechanisms, Clinical Practice, and Emerging Therapeutics (Deadline: 31 May 2024)
- Clinical Outcomes in Urologic Cancers (Deadline: 30 June 2024)
- Clinical Research Advances in Chronic Lymphocytic Leukemia (CLL) (Deadline: 30 June 2024)
- Clinics and Research in Recurrent Hepatocellular Carcinoma (Deadline: 30 June 2024)
- Clinicopathological Study of Gynecologic Cancer (Deadline: 30 June 2024)
- Clinical and Translational Updates in Renal Cell Carcinoma (Deadline: 2 July 2024)
- Novel Researches on Diagnosis and Treatment of Melanoma (Deadline: 30 July 2024)
- Updates on Oncoplastic Techniques (Deadline: 31 August 2024)
- Editorial Board Members' Collection Series: Advances in Colorectal Cancer Diagnostics and Treatments (Deadline: 31 August 2024)
- Neuroendocrine Tumors: Clinical and Translational Research (Deadline: 30 September 2024)
- Endometrial Cancer: Clinical Outcomes and Management (Deadline: 31 October 2024)
Topical Collection
Following topical collection within this section is currently open for submissions:
